| Literature DB >> 28832557 |
Jiamei Lu1, Xiaofen Zeng1, Jinlian Liao1, Yong Zhang1, Li Yang2, Yuming Li3, Jun Lv4.
Abstract
BACKGROUND Nasopharyngeal carcinoma (NPC) is endemic in China and patient self-management is poor. Minorities may suffer from psychological problems during treatments for NPC. This study aimed to implement an intervention to promote self-efficacy of minority patients (Zhuang tribe, Guangxi, China) with NPC to improve their quality of life (QOL). MATERIAL AND METHODS This was a prospective study of 120 patients with NPC treated at the First Affiliated Hospital of Guangxi Medical University (Guangxi, China), randomized to conventional care (n=60, controls) or conventional care plus self-efficacy interventions based on health education, behavior therapy, and psychological intervention (n=60, self-efficacy group). Self-efficacy was evaluated using the general self-efficacy scale, and QOL using the EORTC QLQ-C30. The questionnaires were completed at discharge, at 6 months, and at 1 and 2 years. The primary outcome was QOL. RESULTS There was no difference in QOL at baseline. From study start to hospital discharge, overall QOL scores decreased in both groups, but this decrease was more important in the control group (controls: -39.31 vs. self-efficacy: -27.04, P<0.05). After discharge, each functional field QOL scores and overall QOL increased with time in the 2 groups, and they were significantly higher in the self-efficacy group. CONCLUSIONS This intervention promoting self-efficacy could increase patients' own potential and initiative, enhance their confidence and ability to solve health problems, improve their coping with adverse effects of treatments, and have positive effects on their QOL. Self-efficacy theory-based interventions could be worth popularization during the treatment and recovery of minority patients with NPC.Entities:
Mesh:
Year: 2017 PMID: 28832557 PMCID: PMC5578692 DOI: 10.12659/msm.903205
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Radiotherapy and chemotherapy given to the patients with NPC.
| Treatment | Details |
|---|---|
| Radiotherapy |
– Gross tumor volume of the nasopharynx: dose of 70–74 Gy – Gross tumor volume of cervical lymph nodes: dose of 68–70 Gy – Clinical target volume 1 – Clinical target volume 2 – Treatments were given once a day, 5 times/week, for 6 weeks, for a total of 30 days. |
| Neoadjuvant chemotherapy | Cisplatin–based concurrent chemotherapy, mainly with 80–100 mg/m2 on days 1–2 every 3 weeks, for 2–3 cycles |
| Concurrent chemotherapy | Two cycles of DF (cisplatin [25 mg/m2 on days 1–3] and 5–fluorouracil [750 mg/m2 on days 1–5]) |
Defined as the gross tumor volume of the nasopharynx +5–10 mm margin, and the range depended on the adjacent texture characteristic, including pharyngonasal cavity mucosa and submucosal 5 mm;
defined as the area that the NPC might extend to, including skull base, the posterior ethmoid sinus, sphenoid sinus bottom, the posterior third of the nasal cavity, pterygoid process, pterygopalatine fossa, parapharyngeal space, retropharyngeal space, and the size of the negative regional lymph nodes.
Figure 1Health education pathway for NPC in the self-efficacy group.
Characteristics of the patients.
| Controls | Self-efficacy | P | |
|---|---|---|---|
| N | 53 | 53 | |
|
| |||
| Sex | 0.824 | ||
| Female | 13 | 14 | |
| Male | 40 | 39 | |
|
| |||
| Age (years) | 51.5 (20–68) | 52.1 (21–70) | 0.631 |
|
| |||
| Family monthly income | 0.993 | ||
| <¥ 800 | 18 | 18 | |
| ¥ 800–1500 | 15 | 16 | |
| ¥ 1500–3000 | 9 | 9 | |
| ¥ 3000–5000 | 7 | 6 | |
| >¥ 5000 | 4 | 3 | |
|
| |||
| Tumor differentiation | 0.978 | ||
| Moderate | 7 | 7 | |
| Poor | 18 | 19 | |
| Undifferentiated | 28 | 27 | |
|
| |||
| Clinical stage | 0.821 | ||
| I | 6 | 4 | |
| II | 9 | 10 | |
| III | 28 | 26 | |
| IV | 10 | 13 | |
|
| |||
| Treatment approach | |||
| Chemotherapy | 0.672 | ||
| Neoadjuvant + concurrent chemotherapy | 38 | 36 | |
| Concurrent chemotherapy | 15 | ||
| Radiotherapy | 17 | 1.000 | |
| Intensity-modulated radiation therapy | 53 | 53 | |
Comparison of self-efficacy and depression symptoms between the two groups before and during radiotherapy.
| Group | Before | During radiotherapy | ||
|---|---|---|---|---|
| Days 1 to 10 | Days 11 to 20 | Days >21 | ||
| Self-Efficacy | ||||
| Controls (n=53) | 27.6±4.3 | 27.0±3.2 | 25.2±3.6 | 24.3±3.3 |
| Self-efficacy (n=53) | 27.4±4.6 | 29.6±3.2 | 28.7±2.7 | 29.3±2.7 |
| P | 0.814 | <0.001 | <0.001 | <0.001 |
| SDS | ||||
| Controls (n=53) | 46.3±5.5 | 50.5±4.9 | 58.3±4.5 | 63.2±6.9 |
| Self-efficacy (n=53) | 46.8±5.2 | 48.1±4.8 | 53.9±4.8 | 58.9±4.4 |
| P | 0.444 | <0.001 | <0.001 | <0.001 |
Figure 2Changes in time in indicators of QOL between the 2 groups.